Indications & Usage
Directions: FOR ORAL USE ONLY.
Olibanum Belladonna Comp. Liquid
FDA Label NDC 48951-7213
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy, Inc for the product Olibanum Belladonna Comp. (NDC 48951-7213). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage, dosage & administration, otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, warnings, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Take 3-4 times daily. Ages 12 and older: 10 drops.
Ages 2-11: 5 drops. Under age 2: Consult a doctor.
Otc - Active Ingredient
Active Ingredient: 100gm contains: 2.5gm Onopordon (Cotton thistle) 1X, 2.5gm Primula (Cowslip) 1X; Hyoscyamus (Henbane) 3X, Myrrha (Myrrh resin) 6X, Atropa belladonna e rad. (Nightshade) 10X, Olibanum (Frankincense) 12X, Aurum met. (Metallic gold) 30X
Inactive Ingredient
Inactive Ingredients: Distilled water, 20% Organic cane alcohol, Lactose
Prepared using rhythmical processes.
Otc - Purpose
Use: Temporary relief of headache.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Warnings
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Contains traces of lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.
Otc - Questions
Questions? Call 866.642.2858
Made with care by Uriel, East Troy, WI 53120
shopuriel.com Lot:
* Please review the disclaimer below.
